Clinical trial
Ologen (OculusGen)-Phacotrabeculectomy Historical Control Study in India
NCT00477685 · Pro Top & Mediking Company Limited, Industry · Completed
Key facts
| NCT number | NCT00477685 |
|---|---|
| Title | Ologen (OculusGen)-Phacotrabeculectomy Historical Control Study in India |
| Official title | Study of the Safety and Effectiveness of the OculusGenTM Collagen Matrix Implant as an Aid in Phacotrabeculectomy Surgery |
| Lead sponsor | Pro Top & Mediking Company Limited, Industry |
| Status | Completed |
| Study type | Observational [Patient Registry] |
| Conditions | Glaucoma, Cataract |
| Intervention type | Device |
| Interventions | OculusGen Biodegradable Collagen Matrix Implant |
| Enrollment | 10 |
| Start date | May 1, 2007 |
| Primary completion | Oct 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | May 24, 2007 |
| Last update posted | Aug 14, 2017 |
| Countries | India |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: